Rxo (RXO) Depreciation & Amortization (CF) (2021 - 2025)
Rxo's Depreciation & Amortization (CF) history spans 5 years, with the latest figure at $28.0 million for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 15.15% year-over-year to $28.0 million; the TTM value through Dec 2025 reached $116.0 million, up 33.33%, while the annual FY2025 figure was $116.0 million, 33.33% up from the prior year.
- Depreciation & Amortization (CF) reached $28.0 million in Q4 2025 per RXO's latest filing, up from $26.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $33.0 million in Q4 2024 to a low of $15.0 million in Q4 2023.
- Average Depreciation & Amortization (CF) over 5 years is $22.1 million, with a median of $21.0 million recorded in 2022.
- Peak YoY movement for Depreciation & Amortization (CF): tumbled 30.43% in 2023, then skyrocketed 120.0% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $19.0 million in 2021, then grew by 10.53% to $21.0 million in 2022, then fell by 28.57% to $15.0 million in 2023, then soared by 120.0% to $33.0 million in 2024, then dropped by 15.15% to $28.0 million in 2025.
- Per Business Quant, the three most recent readings for RXO's Depreciation & Amortization (CF) are $28.0 million (Q4 2025), $26.0 million (Q3 2025), and $30.0 million (Q2 2025).